# FDA Inspection 1202190 - Koligo Therapeutics Inc - February 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/koligo-therapeutics-inc/44a9e26d-65cd-4ec4-99e5-81deefa23174
Source feed: FDA_Inspections

> FDA Inspection 1202190 for Koligo Therapeutics Inc on February 28, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202190
- Company Name: Koligo Therapeutics Inc
- Inspection Date: 2023-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1202190 - 2023-02-28](https://www.keypedia.com/records/fda_inspections/koligo-therapeutics-inc/02f59933-84cd-41e4-8496-58ff2796649f)

Company: https://www.keypedia.com/companies/koligo-therapeutics-inc/b86d1c48-1375-4af0-9967-562712f87ca4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d